Johan Kløvgaard Sørensen

Johan Kløvgaard Sørensen

Auto-generated profile, based on publicly available information

Johan Kløvgaard Sørensen

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2024 in Pain
Verified
Journal Article
Closed access
NPNicholas Papadomanolakis-Pakis
Nicholas Papadomanolakis-Pakis
SHSimon Haroutounian
Simon Haroutounian
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
CRCharlotte Runge
Charlotte Runge
LBLone Dragnes Brix
Lone Dragnes Brix
LNLone Nikolajsen
Lone Nikolajsen
Chronic postsurgical pain (CPSP) is a highly prevalent condition. To improve CPSP management, we aimed to develop and internally validate generalizable point-of-care risk tools for preoperative and postoperative prediction of CPSP 3 months after surgery. A multicentre, prospective, cohort study in adult patients undergoing elective surgery was conducted between May 2021 and May 2023. Prediction models were developed for the primary outcome according to the International Association for the Study of Pain criteria and a secondary threshold-based CPSP outcome. Models were developed with multivariable logistic regression and backward stepwise selection. Internal validation was conducted using bootstrap resampling, and optimism was corrected by shrinkage of predictor weights. Model performance was assessed by discrimination and calibration. Clinical utility was assessed by decision curve analysis. The final cohort included 960 patients, 16.3% experienced CPSP according to the primary outcome and 33.6% according to the secondary outcome. The primary CPSP model included age and presence of other preoperative pain. Predictors in the threshold-based models associated with an increased risk of CPSP included younger age, female sex, preoperative pain in the surgical area, other preoperative pain, orthopedic surgery, minimally invasive surgery, expected surgery duration, and acute postsurgical pain intensity. Optimism-corrected area-under-the-receiver-operating curves for preoperative and postoperative threshold-based models were 0.748 and 0.747, respectively. These models demonstrated good calibration and clinical utility. The primary CPSP model demonstrated fair predictive performance including 2 significant predictors. Derivation of a generalizable risk tool with point-of-care predictors was possible for the threshold-based CPSP models but requires independent validation.

16 July 2024 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
UGUlrik Grevstad
Ulrik Grevstad
PJPia Jaeger
Pia Jaeger
LNLone Nikolajsen
Lone Nikolajsen
CRCharlotte Runge
Charlotte Runge
Background and objectives Motor-sparing peripheral nerve blocks enhance multimodal opioid-sparing strategies after total knee arthroplasty. We hypothesized that adding a popliteal plexus block to a femoral triangle block could reduce 24-hour opioid consumption after total knee arthroplasty, compared with standalone femoral triangle block or adductor canal block. Methods This patient- and assessor-blinded, randomized controlled trial allocated 165 patients into three equally sized parallel groups, receiving either 1) popliteal plexus block+femoral triangle block, 2) femoral triangle block, or 3) adductor canal block. Intravenous oxycodone was administered via patient-controlled analgesia pumps. The primary outcome was 24-hour postoperative opioid consumption. Secondary outcomes were preoperative maximum voluntary isometric contraction and manual muscle tests of knee and ankle movement assessed before and after the nerve block procedure together with postoperative pain scores, mobilization, and 12-hour opioid consumption. Results 24-hour postoperative intravenous oxycodone consumption varied significantly between groups (p<0.01), with medians (IQR) of 6 mg (2–12) in the popliteal plexus block+femoral triangle block group, 10 mg (8–16) in the femoral triangle block group, and 12 mg (6–18) in the adductor canal block group. Median consumption in the popliteal plexus block+femoral triangle block group was reduced by −4 mg (95% CI −7.4 to –1.0, p<0.01) and −6 mg (95% CI −8.3 to –1.3, p=0.01) compared with groups of femoral triangle block and adductor canal block, respectively. No differences were found in pain scores, mobilization, or changes in preoperative muscle strength. Post hoc analysis revealed successful 24-hour opioid-free postoperative care among 12 patients with popliteal plexus block+femoral triangle block, as compared with two with femoral triangle block and six with adductor canal block. Conclusion Adding a popliteal plexus block to a femoral triangle block resulted in a statistically significant reduction of 24-hour postoperative opioid consumption after total knee arthroplasty. However, no differences were found in pain scores. Popliteal plexus block did not impair the lower leg muscles.

3 April 2025 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
UGUlrik Grevstad
Ulrik Grevstad
EQErisela Qerama
Erisela Qerama
LBLine Stenholt Bruun
Line Stenholt Bruun
LNLone Nikolajsen
Lone Nikolajsen
CRCharlotte Runge
Charlotte Runge
Background and objectives Popliteal plexus block (PPB) has shown moderate improvements in multimodal analgesia following total knee arthroplasty (TKA) while preserving motor function. However, the optimal analgesic volume for PPB remains unknown, and concerns exist regarding potential volume-dependent motor nerve involvement. This study investigates whether increasing the volume of local anesthetic for PPB affects muscle function and motor nerve involvement. Methods In this randomized, controlled, blinded trial, 40 healthy volunteers received one active nerve block and one sham block in each leg. Participants were randomized into three PPB groups receiving 10 mL, 20 mL, or 30 mL of 1% lidocaine, with 20 observations per group. Additionally, 10 femoral nerve blocks and 10 sciatic nerve blocks were included as reference groups to confirm motor nerve involvement. The primary outcome was relative changes in maximum voluntary isometric contraction (MVIC) of ankle plantar- and dorsiflexion. Secondary outcomes included relative changes in MVIC of knee extension, relative changes in compound muscle action potential of the gastrocnemius, anterior tibial, vastus medialis, and vastus lateralis muscles and frequency of saphenous nerve involvement. Results There were no significant differences in motor function between the three PPB groups for any MVIC measures (p≥0.1). Compound muscle action potential changes did not indicate clinically relevant motor nerve involvement across PPB groups. Saphenous nerve involvement was inconsistent, affecting 40% (10 mL), 40% (20 mL), and 60% (30 mL) of cases (p=0.3), suggesting ineffective sensory block of the femoral nerve’s medial knee contributions. Conclusion Increasing the volume of local anesthetic for PPB does not impair muscle function or significantly involve motor nerves, supporting its motor-sparing efficacy. PPB inconsistently affects the femoral nerve’s sensory contributions to the knee, emphasizing its role as an adjunct to femoral triangle or adductor canal blocks in clinical practice. Concerns of muscle impairment should not hinder future clinical trials from exploration of the optimal analgesic volume for PPB. Trial registration number NCT05464862.

10 May 2025 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
MJMikkel Schjødt Heide Jensen
Mikkel Schjødt Heide Jensen
UGUlrik Grevstad
Ulrik Grevstad
LNLone Nikolajsen
Lone Nikolajsen
CRCharlotte Runge
Charlotte Runge
Background: Adjunct treatment with a popliteal plexus block (PPB) provides moderate enhancement to multimodal analgesic regimens following total knee arthroplasty while maintaining motor function. However, the optimal anesthetic volume of local anesthetic for PPB remains unknown.Aim: To compare the analgesic effects of PPB with 10 versus 20 mL of local anesthetics as an adjunct to a femoral triangle block after total knee arthroplasty.Methods: This blinded, controlled, randomized clinical trial will include 120 patients, randomly assigned to receive PPB with either 10 or 20 mL of bupivacaine 5 mg/mL. All patients undergo primary total knee arthroplasty under spinal anesthesia and receive a multimodal analgesia regimen, including paracetamol, ibuprofen, opioids, dexamethasone, and a femoral triangle block.Outcomes: Primary outcome is 24‐h postoperative opioid consumption. Secondary outcomes include the frequency of patients with opioid‐free analgesia in the first 24 h after surgery, postoperative pain intensity at rest and during mobilization, postoperative muscle function of the leg, ability to mobilize with crutches 6 h after surgery, and Quality of Recovery‐15 survey at 24 h after surgery.Conclusion: This trial hopes to optimize postoperative pain management after total knee arthroplasty by providing valuable insights into the optimal analgesic volume for PPB.Trial Registration: Danish Data Protection Agency: 693807, clinicaltrials.gov: NCT06908837, CTIS: 2024‐520204‐26‐00

18 March 2026 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
MJMikkel Schjødt Heide Jensen
Mikkel Schjødt Heide Jensen
UGUlrik Grevstad
Ulrik Grevstad
LNLone Nikolajsen
Lone Nikolajsen
CRCharlotte Runge
Charlotte Runge
Background and objectives: The popliteal plexus block is a motor-sparing regional anesthetic technique used as an adjunct to multimodal analgesia after total knee arthroplasty. Clinical studies have used varying local anesthetic volumes for the block, reflecting uncertainty regarding the optimal volume. This randomized clinical trial aimed to determine whether using 20 mL of local anesthetic for the popliteal plexus block provides superior analgesic efficacy and early functional outcomes compared with 10 mL after total knee arthroplasty. Methods: In this single-center, blinded, randomized controlled trial, 120 adults undergoing primary unilateral total knee arthroplasty under spinal anesthesia were randomized to receive a popliteal plexus block with either 10 mL or 20 mL of bupivacaine 5 mg/mL, in addition to a standardized multimodal analgesic regimen including a femoral triangle block. The primary outcome was 24-hour postoperative opioid consumption. Secondary outcomes included the proportion of patients achieving opioid-free analgesia, pain scores, early functional outcomes and patient-reported Quality of Recovery-15. Results: No statistically significant or clinically relevant differences were observed between the two groups in 24-hour postoperative opioid consumption (median 15 (IQR 3.75–30) vs 15 mg (IQR 0–30) oral morphine milligram equivalents; median difference 0 mg, 95% CI −10 to 5; p=0.6), the proportion of patients achieving opioid-free analgesia, pain at rest or during ambulation, ability to ambulate with crutches, motor impairment, or patient-reported quality of recovery. Conclusions: Use of 20 mL of local anesthetic for the popliteal plexus block as part of a multimodal analgesic regimen after total knee arthroplasty does not provide superior analgesic efficacy or improved functional outcomes compared with 10 mL. Consistent with the principle of using the lowest effective dose and minimizing cumulative local anesthetic exposure, these findings support the use of 10 mL of local anesthetic for popliteal plexus block in clinical practice and in future research. Trial registration number: EUCT number: 2024-520204-26-00.

27 August 2024 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
MJMikkel Schjødt Heide Jensen
Mikkel Schjødt Heide Jensen
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
LNLone Nikolajsen
Lone Nikolajsen
CRCharlotte Runge
Charlotte Runge
Background: Peripheral nerve blocks effectively alleviate postoperative pain. Animal studies and human research suggest that opioid tolerance may reduce the effectiveness of local analgesics. The reduced effectiveness has been observed in opioid‐tolerant humans and animals undergoing spinal and infiltration anaesthesia with both lidocaine and bupivacaine. However, the impact on peripheral nerve blocks in humans has not been evaluated. This study aims to assess the onset time and duration of a radial nerve block in opioid‐tolerant individuals compared to opioid‐naive individuals. We hypothesise that peripheral nerve blocks may be less effective in producing sensory and motor blockades in opioid‐tolerant individuals compared to their opioid‐naive counterparts.Methods: Twenty opioid‐tolerant individuals will be matched by sex and age with opioid‐naïve counterparts. Participants will receive an ultrasound‐guided radial nerve block. The primary outcome is the difference in the duration of sensory nerve blockade between the two groups. The secondary outcomes include the onset time of sensory blockade, onset time of motor blockade, and difference in duration of motor nerve blockade.Conclusion: This study will compare the effectiveness of a peripheral nerve block between opioid‐tolerant and opioid‐naïve individuals. Any found differences could support a specific postoperative protocol for opioid‐tolerant individuals regarding the use of peripheral nerve blocks.